TPG’s AskBio stake more than doubles amid sale to Bayer
Bayer agreed to pay $2bn upfront for the TPG-backed gene therapy company, plus a potential for another $2bn in milestone payments.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .-
Sign in or Register
-
Issues with signing in? Click here
Don't have an account? Register now
-
